
Opinion|Podcasts|September 29, 2023
Untapped Potentials: Exploring Overlooked Therapies for Type 2 Diabetes
Listen
0:00 / 0:00
In this episode of MEDcast, the expert panelists examine some underutilized therapies in type 2 diabetes (T2D) and explore their potential as effective treatment choices for many patients.
Advertisement
0:50 Need for using older diabetes medications
3:30 Quick-release bromocriptine: benefits in T2D and cardiovascular risk
6:15 Efficacy of quick-release bromocriptine
8:10 Quick-release bromocriptine as monotherapy and as an add-on
9:00 Mechanism of quick-release bromocriptine
11:41 Titrating quick-release bromocriptine
15:50 Benefits of pioglitazone
22:30 Positioning older T2D therapies in the current treatment regimen
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
GLP-1s Move Beyond Diabetes as Core Kidney-Protective Therapy
2
Nerandomilast Reduces Mortality Risk in Pulmonary Fibrosis Analysis
3
6 Cardiology Headlines You Missed in July 2026
4
What EASI 75, vIGA-AD Scores Reveal About Tapinarof's Eczema Efficacy
5





































































